THERAPEUTIC DRUG MONITORING

THERAPEUTIC DRUG MONITORING

THER DRUG MONIT
影响因子:2.4
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Lippincott Williams and Wilkins Ltd.
发刊时间:1979
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:0163-4356

期刊介绍

Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, pathology, toxicology, analytical chemistry–that share a common interest in Therapeutic Drug Monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles.
《治疗性药物监测》是一份经过同行评审的多学科期刊,面向药理学家、临床化学家、实验室工作者、药剂师、药物研究人员和毒理学家。它促进了临床药理学、病理学、毒理学、分析化学等不同学科之间的知识交流,这些学科在治疗药物监测方面有着共同的兴趣。该杂志详细介绍了影响药物吸收、代谢和排泄速度和程度的各种因素。常规功能包括特定类别药物的综述文章、原创文章、病例报告、技术说明和继续教育文章。
年发文量 104
国人发稿量 8.91
国人发文占比 0.09%
自引率 -
平均录取率0
平均审稿周期 偏慢,4-8周
版面费 -
偏重研究方向 医学-毒理学
期刊官网 http://journals.lww.com/drug-monitoring/pages/currenttoc.aspx
投稿链接 https://www.editorialmanager.com/TDM

期刊高被引文献

Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000601
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000654
Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000605
Concentration–Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000582
Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000572
Short communication: Pre-analytical stability of piperacillin, tazobactam, meropenem and ceftazidime in plasma and whole blood using LC-MS/MS.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000650
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000719
Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000637
Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000599
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000569
A Short Communication: Lamotrigine Levels in Milk, Mothers, and Breastfed Infants During the First Postnatal Month
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000604
Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000568
Clinical Validation of a Dried Blood Spot Assay for 8 Antihypertensive Drugs and 4 Active Metabolites.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000703
Distinguishing between cyclopropylfentanyl and crotonylfentanyl by methods commonly available in the forensic laboratory.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000617
Dried blood microsampling-based therapeutic drug monitoring of anti-epileptic drugs in children with nodding syndrome and epilepsy in Uganda and the Democratic Republic of the Congo.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000720
A Compilation of Serum Concentrations of 12 Antipsychotic Drugs in a Therapeutic Drug Monitoring Setting
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000585
Ganciclovir Therapeutic Drug Monitoring: A Case Series.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000598
Impact of CYP2C19 phenotypes on clinical efficacy of stiripentol in Japanese patients with Dravet syndrome.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000676
Chinese patients with heart valve replacement do not benefit from warfarin pharmacogenetic testing on anticoagulation outcomes.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000664
A short communication: Is there a temporal relationship between trough whole blood tacrolimus concentration and acute rejection in the first 14 days after kidney transplantation?
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000656
Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000632
Therapeutic Drug Monitoring in Pregnant Patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000709
Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis.
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000631
Pharmacodynamic Monitoring of mTOR Inhibitors
来源期刊:Therapeutic Drug MonitoringDOI:10.1097/FTD.0000000000000616
Population pharmacokinetic analysis of phenytoin after intravenous administration of fosphenytoin in adult and elderly epileptic patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000651
A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000707
Development and validation of a fast U-HPLC-fluorescent method for the quantification of hydroxychloroquine and its metabolites in patients with lupus.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000614
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000699
Association of hepatic nuclear factor 4 alpha gene polymorphisms with free Imatinib plasma levels and adverse reactions in Chinese gastrointestinal stromal tumor patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000642
Increased arbekacin clearance in patients with febrile neutropenia.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000678
Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000587
A prospective investigation of the performance of two gamma-hydroxybutyric acid (GHB) tests: DrugCheck GHB Single Test and Viva-EGHB immunoassay.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000677
Strategies for Individualized Dosing of Clotting Factor Concentrates and Desmopressin in Hemophilia A and B.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000625
Tacrolimus levels in the prophylaxis of acute graft-versus-host disease in Chinese early after hematopoietic stem cell transplantation.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000645
Quantification of the plasma concentration of apatinib by two-dimensional liquid chromatography (2D-LC).
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000609
Dosing Requirements of Extended-Release Tacrolimus (Astagraf XL) in African American Kidney Transplant Recipients Converted from Immediate Release Tacrolimus (AAAKTRS).
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000722
A Dried Blood Spot Analysis for Solithromycin in Adolescents, Children, and Infants: A Short Communication.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000670
Short communication: Distribution of psychotropic drugs into lipoproteins.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000660
Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000698
TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000718
Improving therapeutic decisions: Pharmacodynamic monitoring as an integral part of Therapeutic Drug Monitoring.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000627
Simple and rapid quantification of the multi-enzyme targeting antifolate pemetrexed in human plasma- A short communication.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000672
Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal Function.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000690
Biomarkers of Drug-Induced Liver Toxicity.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000610
Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000571
Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000591
Population Pharmacokinetics of Vancomycin under Continuous Renal Replacement Therapy using a Polymethylmethacrylate Hemofilter.
来源期刊:Therapeutic drug monitoringDOI:10.1097/ftd.0000000000000721
Biomarkers of Drug-Induced Kidney Toxicity.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000589
Routine Therapeutic Drug Monitoring of Dabigatran: Experience at a Tertiary Center.
来源期刊:Therapeutic drug monitoringDOI:10.1097/FTD.0000000000000713

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
88.46%18.64%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
MEDICAL LABORATORY TECHNOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
MEDICAL LABORATORY TECHNOLOGY 医学实验技术
3区
TOXICOLOGY 毒理学
3区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月升级版
医学4区
MEDICAL LABORATORY TECHNOLOGY 医学实验技术
3区
TOXICOLOGY 毒理学
3区
PHARMACOLOGY & PHARMACY 药学
4区
2022年12月旧的升级版
医学3区
PHARMACOLOGY & PHARMACY 药学
3区
MEDICAL LABORATORY TECHNOLOGY 医学实验技术
3区
TOXICOLOGY 毒理学
3区